EBN-32483-68932 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-05
Dose 1 — Pfizer-BioNTech
2021-11-06
Registered in v-safe
2021-11-06
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-11-08
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-11-09
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · None

Adult check-in
2021-11-11
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Fair · Fever · Headache, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school

Adult check-in
2021-11-12
Health check-in — day 7, dose 1, dependent
Feeling: Fair · Fever · Headache, Joint pains · Be unable to work or attend school

Adult check-in
2021-11-19
Health check-in — day 14, dose 1, dependent
Feeling: Good

Adult check-in
2021-11-28
Health check-in — day 21, dose 1, dependent
Feeling: Good

Adult check-in
2022-02-05
Health check-in — 3 months, dose 1, dependent
Feeling: Good

Adult check-in
2022-11-05
Survey response — 12 months, dose 1, dependent
MedDRA: Headache, Pyrexia, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Fever, congestion, headache

MedDRA releases: 2024-11 · check-in free text available
2022-11-05
Report sent to call center — 12 months, dose 1, dependent
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-07
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-05	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-11-05	Unsuccessful

Free text

Release 12 — 12 months, dose 1, dependent

2022-11-05

Symptoms: Fever, congestion, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release